There has been criticism that the ‘genetic revolution’ heralded by the completion of the Human Genome Project has failed to meet the more optimistic expectations of 15 years ago and that patient outcomes have not materially improved. This column analyses the extent to which basic genetic science has fuelled early-stage drug innovation. The results suggest that alleged ‘slower-than-expected’ progress has been partly caused by the amount of complexity in human biology, which was unexpected prior to the Project’s completion but has been progressively revealed since then.
Related
-
Harald Hau, Ulrich Hege
Most Read
-
Calvano, Calzolari, Denicolò, Pastorello
-
Catillon, Cutler, Getzen
-
Eggertsson, Summers
-
Blundell, Preston
-
Schoenmaker
-
Eichengreen, O'Rourke
-
Eichengreen
-
De Grauwe, Ji
-
Heckman, LaFontaine
-
Krugman
Blogs&Reviews
-
Mancini-Griffoli, Martinez Peria, Agur, Ari, Kiff, Popescu, Rochon, Jakab
-
Mody
-
Felbermayr, Fuest, Gersbach, Ritschl, Thum, Braml
-
Ambrocio, Hasan, Jokivuolle, Ristolainen
-
Beck
Vox eBooks
Don't Miss
Eggertsson, Summers
Crowley, Exton, Han
Allen, Dobbin, Morten
Events
-
18 - 19 February 2019 / London / CEPR
-
15 - 15 March 2019 / London, Royal Society / UK Network of Environmental Economists (UKNEE)
-
28 - 29 March 2019 / European Central Bank, Frankfurt / European Central Bank and the University of Ohio
-
28 - 29 March 2019 / Paris / SUERF - The European Money and Finance Forum Banque de France (BDF)
-
3 - 4 May 2019 / London / Queen Mary, University of London
CEPR Policy Research
-
Gobillon, Solignac
-
Giglio, Maggiori, Stroebel, Weber
-
Summers, Fatás
-
Favero, Galasso
-
Butt, Churm, McMahon, Morotz, Schanz
-
Eichengreen, Avgouleas, Poiares Maduro, Panizza, Portes, Weder di Mauro, Wyplosz, Zettelmeyer
-
Baldwin, Beck, Bénassy-Quéré, Blanchard, Corsetti, De Grauwe, den Haan, Giavazzi, Gros, Kalemli-Ozcan, Micossi, Papaioannou, Pesenti, Pissarides , Tabellini, Weder di Mauro
-
Baldwin, Nakatomi
-
Thimann
-
Goodhart, Perotti